Sumitomo Mitsui Trust Holdings Inc. increased its holdings in shares of Medidata Solutions Inc (NASDAQ:MDSO) by 16.0% during the 1st quarter, HoldingsChannel reports. The firm owned 1,250,464 shares of the company’s stock after purchasing an additional 172,074 shares during the period. Sumitomo Mitsui Trust Holdings Inc.’s holdings in Medidata Solutions were worth $91,584,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in MDSO. Arcadia Investment Management Corp MI increased its position in shares of Medidata Solutions by 1.1% during the 1st quarter. Arcadia Investment Management Corp MI now owns 56,141 shares of the company’s stock worth $4,112,000 after purchasing an additional 600 shares during the last quarter. Virginia Retirement Systems ET AL acquired a new position in shares of Medidata Solutions during the 4th quarter worth approximately $452,000. BlackRock Inc. increased its position in shares of Medidata Solutions by 2.9% during the 4th quarter. BlackRock Inc. now owns 6,995,601 shares of the company’s stock worth $471,644,000 after purchasing an additional 195,763 shares during the last quarter. American International Group Inc. increased its position in shares of Medidata Solutions by 1.9% during the 4th quarter. American International Group Inc. now owns 161,630 shares of the company’s stock worth $10,897,000 after purchasing an additional 3,091 shares during the last quarter. Finally, Janus Henderson Group PLC increased its position in shares of Medidata Solutions by 6.0% during the 1st quarter. Janus Henderson Group PLC now owns 1,837,555 shares of the company’s stock worth $134,583,000 after purchasing an additional 103,716 shares during the last quarter.

MDSO has been the subject of several research analyst reports. Zacks Investment Research upgraded Medidata Solutions from a “sell” rating to a “hold” rating in a research note on Wednesday, March 6th. BidaskClub upgraded Medidata Solutions from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, March 20th. TheStreet upgraded Medidata Solutions from a “c+” rating to a “b-” rating in a research note on Friday, March 15th. Finally, Guggenheim initiated coverage on Medidata Solutions in a research note on Wednesday, April 17th. They set a “buy” rating and a $92.00 target price for the company. Two analysts have rated the stock with a sell rating, seven have given a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $84.28.

MDSO traded down $1.39 during trading on Thursday, hitting $90.28. The stock had a trading volume of 9,264 shares, compared to its average volume of 1,029,365. The company has a market capitalization of $5.66 billion, a PE ratio of 93.75, a price-to-earnings-growth ratio of 8.25 and a beta of 1.42. Medidata Solutions Inc has a one year low of $60.10 and a one year high of $98.60. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.57 and a quick ratio of 2.57.

Medidata Solutions (NASDAQ:MDSO) last released its quarterly earnings results on Tuesday, April 30th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.12 by $0.33. The business had revenue of $173.50 million during the quarter, compared to the consensus estimate of $172.12 million. Medidata Solutions had a return on equity of 9.28% and a net margin of 7.99%. The firm’s quarterly revenue was up 16.3% on a year-over-year basis. During the same period in the previous year, the company posted $0.40 EPS. Equities analysts anticipate that Medidata Solutions Inc will post 0.79 earnings per share for the current fiscal year.

In other news, EVP Daniel Patrick Shannon sold 19,725 shares of the company’s stock in a transaction on Tuesday, March 12th. The stock was sold at an average price of $75.17, for a total transaction of $1,482,728.25. Following the completion of the sale, the executive vice president now directly owns 70,497 shares in the company, valued at approximately $5,299,259.49. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Michael Pray sold 15,000 shares of the company’s stock in a transaction on Friday, March 1st. The shares were sold at an average price of $76.50, for a total value of $1,147,500.00. Following the sale, the executive vice president now owns 77,134 shares of the company’s stock, valued at $5,900,751. The disclosure for this sale can be found here. Insiders own 4.70% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Medidata Solutions Inc (MDSO) Stake Boosted by Sumitomo Mitsui Trust Holdings Inc.” was originally published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece on another website, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this piece can be read at https://theolympiareport.com/2019/05/23/medidata-solutions-inc-mdso-stake-boosted-by-sumitomo-mitsui-trust-holdings-inc.html.

Medidata Solutions Profile

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.

Featured Story: Municipal Bonds

Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions Inc (NASDAQ:MDSO).

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.